According to this possibility, CTBP2 repression of fatty acid in breast cancer requires the interaction with the transcriptional repressor ZEB1, which was never detected as a CTBP2 partner in our co-immunoprecipitation analysis in GBM cells. Here, CTBP2 is linked to breast carcinoma.